Outsourcing of research and development (R&D) activities has become a major management issue for R&D and technical managers within firms. It has also been of growing concern to academics who are trying to chart the implications of the increasingly distributed nature of research and innovative activities in advanced economies. This study is based on a survey of research-based pharmaceutical companies operating in the United Kingdom conducted in [2004][2005][2006]. The aim of this paper is to outline the main reasons for pharmaceutical firms to outsource R&D and the management practices followed by such companies in relation to outsourcing. The research results provide interesting findings in relation to, for example, the reasons behind outsourcing, the decision-making processes behind such practices and barriers to outsourcing arrangements. These issues are evaluated together with the characteristics of the firms and the specific project outsourced. The distinctive nature of R&D outsourcingAlthough there are a number of generic issues and strategies that firms need to be aware of in R&D Management 38, 2,

This paper outlines the knowledge and technology sourcing practices of a range of key firms and organisations across the UK based on primary research, and analyses the key factors related to managing the technological knowledge boundaries of the firm. In particular, the paper considers the dynamic dimension considerations to such issues. As such it outlines important differences between short and long time horizons, before analysing in more detail some of the implications for firms of technological change over the long term. The paper seeks to highlight the importance of the time dimension in helping to explain why and how firms source technological knowledge externally and how they align their sourcing activities to their strategies associated with developing current and future capabilities.

No abstract

No abstract

Absorptive capacity (AC) has been identified as the ability of firms to acquire, assimilate, and apply external knowledge, and thus as a precondition for learning from external knowledge. However, extant literature has focused on AC as (1) a static and (2) a firm-centred concept. In particular, there is little conceptual framing and empirical evidence of how AC develops over time and across boundaries. Taking R&D consortia as the unit of analysis and based on insights from three in-depth case studies of collaborative R&D, our contribution is a framework for AC development over time and across inter-organizational, intraorganizational, and practice boundaries at different stages of collaboration in R&D consortia. Using this framework, we identify a set of mechanisms which enable the development of AC and we discuss the preconditions for these mechanisms. For R&D managers, our research implies that in order to enhance effectiveness of knowledge transfer and learning in R&D consortia they need to develop a strategy that (1) supports learning and AC development throughout the whole cycle of the collaboration, not only by focusing on intra-firm capabilities, but in particular by providing flexible interfaces for overcoming a variety of interaction and learning boundaries between heterogeneous R&D partners, and (2) enables the integration of created and acquired knowledge within the organization once the collaboration is over.